Biotech · Public company · Framingham, MA, US
Xenetic Biosciences, Inc.
Ticker XBIO · SEC CIK 0001534525
Track this companyFree. Adds Xenetic Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- progestin therapyPhase 2 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sodium CridanimodPhase 2 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial CancerPHASE2 · TERMINATED · started Jun 14, 2017ClinicalTrials.gov NCT03077698 · fetched Nov 12, 2026
SEC filings12
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 16, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 7, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-Q FOR JUN 2026SEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORT FOR MARCH 2026SEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-K/A · FORM 10-K FOR DEC 2025 AMENDMENT 1SEC EDGAR · filed Apr 24, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Apr 24, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Mar 13, 2026 · fetched Nov 12, 2026
- 10-K · FORM 10-K FOR DEC 2025SEC EDGAR · filed Mar 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 9, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Dec 11, 2025 · fetched Nov 12, 2026